Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.

To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.

Follow-up period is 2 years.

Inclusion Criteria:

• Mild to moderate glaucoma patients
• Have given written informed consent
• Aged 18 years or older of either sex

Exclusion Criteria:

• Patients not able to understand the character of the study
• Participation in other clinical research within the last 4 weeks
• Patients with end-stage glaucoma
• Patients with glaucoma surgery done before